Collaboration - June 8, 2016
AZ, Foundation Medicine enter strategic collaboration
AstraZeneca has entered into a definitive agreement with Foundation Medicine, Inc. (Foundation Medicine) to develop a novel companion diagnostic assay for Lynparza (olaparib) to support its global development programme. The companion diagnostic will enable physicians to identify those patients most likely to benefit from AstraZeneca’s first-in-class poly ADP-ribose polymerase (PARP) inhibitor. Lynparza is an innovative, […]
Collaboration - June 1, 2016
Swedish Government launch life science program
The Swedish Prime Minister Stefan Löfven has together with the Deputy Prime Minister Isabella Lövin, the Minister of Industry and Innovation Mikael Damberg and the Ministers Sven-Erik Bucht, Karolina Skog, Helene Hellmark Knutsson, Gabriel Wikström and Anna Johansson, launched five strategic collaboration programs, including one for life science. The programs are founded on a developed […]
Collaboration - May 31, 2016
Antaros in collaboration with Sahlgrenska and AstraZeneca
Antaros Medical, Sahlgrenska University Hospital and AstraZeneca have announced a kidney imaging collaboration aiming to develop new tools to treat chronic kidney disease (CKD). The collaboration partners will work together on a study to examine a range of imaging endpoints in patients with CKD. The aim is to determine which imaging biomarkers are best suited to follow CKD progression […]
Collaboration - May 23, 2016
Joint project between UPM and FIMM
The Institute for Molecular Medicine Finland (FIMM), at the University of Helsinki and UPM Biochemicals have started a joint research project with the purpose of investigating the applicability of UPM’s new cellulose-based gel material for cancer research. The project focuses on growing cancer cells on a three-dimensional culture using UPM’s new biomaterial and studying the […]
Collaboration - April 20, 2016
Nuevolution expands collaboration
Nuevolution has announced that Janssen Biotech, one of the Pharmaceutical Companies of Johnson & Johnson, has used its option to expand the collaboration with Nuevolution, thereby providing Nuevolution with a further payment of 600,000 USD. Nuevolution A/S and Janssen Biotech entered into collaboration on 19 October, 2015 for application of Nuevolution’s proprietary Chemetics drug discovery platform […]
Collaboration - April 17, 2016
Orion Corporation enters strategic collaboration
The German Center for Neurodegenerative Diseases and Orion Corporation have agreed to start a strategic collaboration and the aim with the collaboration is to identify novel drug targets and develop treatments for neurodegenerative disorders. Under the terms of the agreement, Orion has the first option to start a research and development collaboration with any individual […]
